Boston Trust Walden’s Essendant Inc. ESND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-24,650
Closed -$753K 351
2016
Q2
$753K Sell
24,650
-1,500
-6% -$47.1K 0.01% 302
2016
Q1
$835K Sell
26,150
-300
-1% -$8.83K 0.01% 299
2015
Q4
$860K Sell
26,450
-3,000
-10% -$102K 0.02% 291
2015
Q3
$955K Sell
29,450
-5,750
-16% -$204K 0.02% 290
2015
Q2
$1.38M Hold
35,200
0.02% 277
2015
Q1
$1.44M Sell
35,200
-1,150
-3% -$46.8K 0.02% 265
2014
Q4
$1.53M Buy
36,350
+2,300
+7% +$93.7K 0.02% 265
2014
Q3
$1.28M Sell
34,050
-500
-1% -$20.1K 0.02% 266
2014
Q2
$1.43M Buy
+34,550
New +$1.35M 0.02% 255
2014
Q1
Sell
-4,800
Closed -$220K 330
2013
Q4
$220K Hold
4,800
﹤0.01% 329
2013
Q3
$209K Buy
+4,800
New +$195K ﹤0.01% 316

Other funds holding ESND

Boston Trust Walden's ESND Position: Q3 2016 in Review

Boston Trust Walden sold out of Essendant Inc. (ESND) in Q3 2016, closing a stake of 24,650 shares — an estimated $753K sold.

Boston Trust Walden first reported a position in ESND in Q3 2013 and held it in 11 quarters. The position peaked at $1.53M in Q4 2014. 131 funds tracked by Wall St. Rank hold ESND as of Q3 2016.

  • Boston Trust Walden reported no remaining Essendant Inc. position as of Q3 2016 after selling out during the quarter.
  • Boston Trust Walden sold 24,650 Essendant Inc. shares in Q3 2016, an estimated $753K.
  • Boston Trust Walden first reported a position in Essendant Inc. in Q3 2013 and held it in 11 quarters.
  • Boston Trust Walden's Essendant Inc. position peaked at $1.53M in Q4 2014.
  • 131 funds tracked by Wall St. Rank held Essendant Inc. as of Q3 2016.

Based on Boston Trust Walden's 13F filing for Q3 2016, filed 17 Oct 2016.